Faculty who have authored publication A phase I and pharmacologic trial of two schedules of the proteasome inhibitor, PS-341 (bortezomib, velcade), in patients with advanced cancer.
Name | Title | Department | Institution |
---|---|---|---|
James P. Thomas MD, PhD | Professor | Medicine | Medical College of Wisconsin |